Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.

Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.

BACKGROUND:Bangladesh is one of the endemic countries for Visceral Leishmaniasis (VL). Médecins Sans Frontières (MSF) ran a VL treatment clinic in the most endemic district (Fulbaria) between 2010 and 2013 using a semi-ambulatory regimen for primary VL of 15 mg/kg Liposomal Amphotericin-B (AmBisome)...

Full description

Bibliographic Details
Main Authors: Emiliano Lucero, Simon M Collin, Sujit Gomes, Fatima Akter, Asaduzzam Asad, Asish Kumar Das, Koert Ritmeijer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-04-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4383421?pdf=render

Internet

http://europepmc.org/articles/PMC4383421?pdf=render

Similar Items